SEARCH

SEARCH BY CITATION

REFERENCES

  • Andersen S, Donnem T, Al-Shibli K, Al-Saad S, Stenvold H, Busund LT, Bremnes RM. 2011. Prognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2. PLoS ONE 6:e19773.
  • Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K. 1997. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89:11751184.
  • Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, Wirtz R, Kuhl M, Wedlich D, Birchmeier W. 1998. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280:596599.
  • Brott BK, Pinsky BA, Erikson RL. 1998. Nlk is a murine protein kinase related to Erk/MAP kinases and localized in the nucleus. Proc Natl Acad Sci USA 95:963968.
  • Cheng X, Liang J, Teng Y, Fu J, Miao S, Zong S, Wang L. 2012. Nemo-like kinase promotes etoposide-induced apoptosis of male germ cell-derived GC-1 cells in vitro. FEBS Lett 586:14971503.
  • Choi KW, Benzer S. 1994. Rotation of photoreceptor clusters in the developing Drosophila eye requires the nemo gene. Cell 78:125136.
  • Cui G, Li Z, Shao B, Zhao L, Zhou Y, Lu T, Wang J, Shi X, Zuo G, Zhu W, Shen A. 2011. Clinical and biological significance of nemo-like kinase expression in glioma. J Clin Neurosci 18:271275.
  • Gu W, Shi XL, Roeder RG. 1997. Synergistic activation of transcription by CBP and p53. Nature 387:819823.
  • Hyodo-Miura J, Urushiyama S, Nagai S, Nishita M, Ueno N, Shibuya H. 2002. Involvement of NLK and Sox11 in neural induction in Xenopus development. Genes Cells 7:487496.
  • Ishitani T, Ninomiya-Tsuji J, Nagai S, Nishita M, Meneghini M, Barker N, Waterman M, Bowerman B, Clevers H, Shibuya H, Matsumoto K. 1999. The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. Nature 399:798802.
  • Ishitani T, Kishida S, Hyodo-Miura J, Ueno N, Yasuda J, Waterman M, Shibuya H, Moon RT, Ninomiya-Tsuji J, Matsumoto K. 2003. The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling. Mol Cell Biol 23:131139.
  • Ishitani T, Hirao T, Suzuki M, Isoda M, Ishitani S, Harigaya K, Kitagawa M, Matsumoto K, Itoh M. 2010. Nemo-like kinase suppresses Notch signalling by interfering with formation of the Notch active transcriptional complex. Nat Cell Biol 12:278285.
  • Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. 2002. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 22:11721183.
  • Jung KH, Kim JK, Noh JH, Eun JW, Bae HJ, Xie HJ, Ahn YM, Park WS, Lee JY, Nam SW. 2010. Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma. J Cell Biochem 110:687696.
  • Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403414.
  • Kanei-Ishii C, Ninomiya-Tsuji J, Tanikawa J, Nomura T, Ishitani T, Kishida S, Kokura K, Kurahashi T, Ichikawa-Iwata E, Kim Y, Matsumoto K, Ishii S. 2004. Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK. Genes Dev 18:816829.
  • Katoh M. 2006. Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades. Cancer Biol Ther 5:10591064.
  • Katoh M. 2007. WNT signaling pathway and stem cell signaling network. Clin Cancer Res 13:40424045.
  • Kim S, Kim Y, Lee J, Chung J. 2010. Regulation of FOXO1 by TAK1-Nemo-like kinase pathway. J Biol Chem 285:81228129.
  • Lee FS, Lane TF, Kuo A, Shackleford GM, Leder P. 1995. Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice. Proc Natl Acad Sci USA 92:22682272.
  • Mazieres J, He B, You L, Xu Z, Jablons DM. 2005. Wnt signaling in lung cancer. Cancer Lett 222:110.
  • Miyazono K. 2000. Positive and negative regulation of TGF-beta signaling. J Cell Sci 113(Pt 7):11011109.
  • Nguyen DX, Chiang AC, Zhang XH, Kim JY, Kris MG, Ladanyi M, Gerald WL, Massague J. 2009. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 138:5162.
  • Niida A, Hiroko T, Kasai M, Furukawa Y, Nakamura Y, Suzuki Y, Sugano S, Akiyama T. 2004. DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene 23:85208526.
  • Ohkawara B, Shirakabe K, Hyodo-Miura J, Matsuo R, Ueno N, Matsumoto K, Shibuya H. 2004. Role of the TAK1-NLK-STAT3 pathway in TGF-beta-mediated mesoderm induction. Genes Dev 18:381386.
  • Okamoto J, Hirata T, Chen Z, Zhou HM, Mikami I, Li H, Yagui-Beltran A, Johansson M, Coussens LM, Clement G, Shi Y, Zhang F, Koizumi K, Shimizu K, Jablons D, He B. 2010. EMX2 is epigenetically silenced and suppresses growth in human lung cancer. Oncogene 29:59695975.
  • Ota R, Kotani T, Yamashita M. 2011. Possible involvement of Nemo-like kinase 1 in Xenopus oocyte maturation as a kinase responsible for Pumilio1, Pumilio2, and CPEB phosphorylation. Biochemistry 50:56485659.
  • Ota S, Ishitani S, Shimizu N, Matsumoto K, Itoh M, Ishitani T. 2012. NLK positively regulates Wnt/beta-catenin signalling by phosphorylating LEF1 in neural progenitor cells. EMBO J 31:19041915.
  • Peifer M, Polakis P. 2000. Wnt signaling in oncogenesis and embryogenesis—A look outside the nucleus. Science 287:16061609.
  • Rosenbluh J, Nijhawan D, Cox AG, Li X, Neal JT, Schafer EJ, Zack TI, Wang X, Tsherniak A, Schinzel AC, Shao DD, Schumacher SE, Weir BA, Vazquez F, Cowley GS, Root DE, Mesirov JP, Beroukhim R, Kuo CJ, Goessling W, Hahn WC. 2012. beta-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell 151:14571473.
  • Sampson EM, Haque ZK, Ku MC, Tevosian SG, Albanese C, Pestell RG, Paulson KE, Yee AS. 2001. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1. EMBO J 20:45004511.
  • Sheng SL, Huang G, Yu B, Qin WX. 2009. Clinical significance and prognostic value of serum Dickkopf-1 concentrations in patients with lung cancer. Clin Chem 55:16561664.
  • Shibuya H, Yamaguchi K, Shirakabe K, Tonegawa A, Gotoh Y, Ueno N, Irie K, Nishida E, Matsumoto K. 1996. TAB1: An activator of the TAK1 MAPKKK in TGF-beta signal transduction. Science 272:11791182.
  • Shin TH, Yasuda J, Rocheleau CE, Lin R, Soto M, Bei Y, Davis RJ, Mello CC. 1999. MOM-4, a MAP kinase kinase kinase-related protein, activates WRM-1/LIT-1 kinase to transduce anterior/posterior polarity signals in C. elegans. Mol Cell 4:275280.
  • Smit L, Baas A, Kuipers J, Korswagen H, van de Wetering M, Clevers H. 2004. Wnt activates the Tak1/Nemo-like kinase pathway. J Biol Chem 279:1723217240.
  • Takada I, Mihara M, Suzawa M, Ohtake F, Kobayashi S, Igarashi M, Youn MY, Takeyama K, Nakamura T, Mezaki Y, Takezawa S, Yogiashi Y, Kitagawa H, Yamada G, Takada S, Minami Y, Shibuya H, Matsumoto K, Kato S. 2007. A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat Cell Biol 9:12731285.
  • Takigawa Y, Brown AM. 2008. Wnt signaling in liver cancer. Curr Drug Targets 9:10131024.
  • Vasil'ev BN, Luchkov AB, Trushin VI, Khazins ED. 1990. The dynamics of the content of incorporated cesium radionuclides in the population of regions with an elevated background radiation. Med Radiol (Mosk) 35:3537.
  • Wodarz A, Nusse R. 1998. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14:5988.
  • Yamada M, Ohnishi J, Ohkawara B, Iemura S, Satoh K, Hyodo-Miura J, Kawachi K, Natsume T, Shibuya H. 2006. NARF, an nemo-like kinase (NLK)-associated ring finger protein regulates the ubiquitylation and degradation of T cell factor/lymphoid enhancer factor (TCF/LEF). J Biol Chem 281:2074920760.
  • Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K. 1995. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270:20082011.
  • Yasuda J, Tsuchiya A, Yamada T, Sakamoto M, Sekiya T, Hirohashi S. 2003. Nemo-like kinase induces apoptosis in DLD-1 human colon cancer cells. Biochem Biophys Res Commun 308:227233.
  • Yasuda J, Yokoo H, Yamada T, Kitabayashi I, Sekiya T, Ichikawa H. 2004. Nemo-like kinase suppresses a wide range of transcription factors, including nuclear factor-kappaB. Cancer Sci 95:5257.
  • Zanotti S, Canalis E. 2012. Nemo-like kinase inhibits osteoblastogenesis by suppressing bone morphogenetic protein and WNT canonical signaling. J Cell Biochem 113:449456.
  • Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry WL III, Lee JJ, Tilghman SM, Gumbiner BM, Costantini F. 1997. The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90:181192.
  • Zeng YA, Rahnama M, Wang S, Sosu-Sedzorme W, Verheyen EM. 2007. Drosophila Nemo antagonizes BMP signaling by phosphorylation of Mad and inhibition of its nuclear accumulation. Development 134:20612071.
  • Zhang Y, Peng C, Wu G, Wang Y, Liu R, Yang S, He S, He F, Yuan Q, Huang Y, Shen A, Cheng C. 2011. Expression of NLK and its potential effect in ovarian cancer chemotherapy. Int J Gynecol Cancer 21:13801387.